A few quotes from an interview with Prof Keith Harding, given Oct2010. May be helpful to keep some of the big picture stuff in mind, as we wait on his fianl report.
'There have been many attempts over recent years to come up with solutions to the problem of non-healing wounds. Unfortunately many of the early attempts
at novel and new therapies for this particular problem have suffered from a lack of good
basic science to underpin the product and many of those products have arrived and failed. The one thing that I have found impressive in working with Tissue Therapies is that they seem to have commitment to understanding the science and managing the development of the product in a structured way.'
'I have been around this subject for nearly 30 years. I have seen a lot of new products come and go. The one thing that was impressive (with Vitrogro) both from the preclinical data and the early clinical studies is that in the clinical studies particularly, there seemed to be a greater consistency of response in the patients that were exposed to this product, far more consistent than I’ve seen with other biological therapies that I personally have been involved in.'
'The potential for VitroGro, if the evidence that emerges supports the data that is already there, is enormous. In many parts of the world many patients with wounds are still treated with very simple basic therapies. It is increasingly recognized that there are many aberrations in that healing process that can occur in a wide range of wound types that are based in abnormalities in the biological response to injury. If VitroGro can correct that abnormality, the potential for replacing a lot of the basic treatment or working in combination with basic treatment to get better clinical results is enormous and I think it is much more important to recognize although there is benefit for Tissue Therapies as an organization, I am confident there will be many patients who will benefit from this biologically based therapy.'
A few quotes from an interview with Prof Keith Harding, given...
Add to My Watchlist
What is My Watchlist?